Breakfast Sessions

Start the day right with an informative and energising Breakfast Session

From 7am to 8.15am on Friday and Saturday, you will have a choice of sessions exploring important clinical areas of health delivered by industry leaders.
Spots are limited, so be sure to include which session you will go to when you register for the Conference!

Breakfast Sessions

Australian’s are avid travellers with over 10 million overseas trips per year. Some of our most popular travel destinations are to developing countries where serious infectious diseases are endemic. Nearly 60% of overseas trips are to countries ‘at-risk’ of travel related disease and only 51% of patients seek pre-travel health information. As such there is a need to be pro-active with pre-travel health advice to ensure that all of our travellers are well informed and prepared for the risks they will face. This interactive session aims to provide the attendees with a process that will ensure that their patients are fully prepared for their upcoming trip. A role play session followed by a case based interactive session will help demonstrate how to implement the process and how to tackle more difficult scenarios.

Caroline Nash, Chair-Elect (Australia) is a Clinical Manager for Aspen Medical, an Australian-owned global provider of healthcare solutions. She has postgraduate qualifications in Public Health, Tropical Medicine, Infection Prevention and Control, Travel Medicine and Immunisation practice. Caroline has undertaken a number of overseas deployments to the Pacific region and to Sierra Leone during the Ebola outbreak. She has studied tropical medicine internationally and has a special interest in Rabies, having co-authored a Rabies awareness brochure for travellers.
Caroline is a Fellow of the Australasian College of Tropical Medicine (FACTM) and a Fellow of the Faculty of Travel Medicine (FFTM). Caroline is passionate about educating travellers and health professional about all aspects of travel medicine. Caroline was elected on to the steering committee of the ISTM Nurses Professional Group (NPG) in 2016.

Danielle Peel is a Nurse Practitioner who has been working in the field of travel medicine for more than 15 years.
Danielle is a co-owner of her own travel medicine clinic in Sydney & an academic at James Cook University. 

The treatment for hepatitis C has changed dramatically in recent years. New curative therapies involve an all-oral (interferon-free) regimens and a shorter period on treatment (generally either 8 or 12 weeks for the majority of patients). The new direct acting antiviral agents (DAAs) are very successful at curing hepatitis C (cure rates >90%) and have few side effects.
Many patients have been treated  in hospital liver clinics, however an increasing number of people living with hepatitis C prefer to be and have been treated successfully in the community. Australian primary care nurses are in a unique position to able to support the ordinary HCV patient in general practice – including baby boomers who may have contracted the virus long ago and migrants from high prevalence HCV regions.
Join us at this breakfast session as fellow nurses provide an overview on how you can support the testing, diagnosis and management of people living with chronic hepatitis C in your general practice.

Over 400,000 Australians are estimated to suffer from a chronic wound at any one time. These impose significant costs to both the health care system and the patient. This session will look at the important role nutrition can play in accelerating the healing process and provide some practical tips on how you can help to make improvements in your patients’ diets.

Dr Jane Winter is the Medical Affairs Manager for Nestle Health Science, Australia. She is an Accredited Practising Dietitian with extensive experience working in hospital, community, academic and government organisations. Jane has recently completed her PhD on the topic of Nutritional Risk in Community Based Older adults. As part of her research, Jane has publications in both Australian and International Journals.

This session will provide an update on the changing epidemiology of invasive meningococcal disease in Australia, current vaccination recommendations,  perspectives and experiences from an Australian GP and patient. The session will include the most recently available data, as well as a panel discussion.

Gabrielle Paris and Dr Rod Pearce are the area experts delivering this session.
Gabrielle Paris BPharm, Medical Science Liaison, GSK Australia, is a registered Pharmacist and graduate from the Victorian College of Pharmacy, Monash University.  As a healthcare professional, Gabrielle is passionate about preventative medicine, particularly in its application to rare and life-threatening vaccine preventable diseases.
Gabrielle has over 15 years’ experience as a clinical pharmacist in the community setting.  She subsequently joined the pharmaceutical industry and applied her experience as a healthcare professional across a range of therapeutic areas, focusing on vaccines for the past 8 years.  Her expertise includes pertussis, travel vaccines and more recently meningococcal.  She is committed to disease prevention by supporting healthcare professionals and empowering patients through education and disease awareness.

 

Dr Pearce trained in Adelaide and worked at the RAH, QEH and Modbury Hospitals before starting work in General Practice.
Dr Pearce was president of the AMA (SA) 1998-2000, GP Nationally Elected Representative on the Federal AMA and Chair of the AMA Council of General Practice for 3 terms from 2004-2010. He is a fellow of the AMA and received the AMA (SA) Presidents award in 2008.
In 2008 he was appointed by the then Health Minister, The Hon. Nicola Roxon to the External Reference Group to develop Australia’s National Primary Health Care Strategy for the national health reforms and was instrumental in Beulah Park and Athelstone Clinics becoming the first in South Australia to train young doctors in their postgraduate (Intern) years and prevocational years (PGPPP) in the community. He continues to be an active supervisor to GP registrars through the regional training program.
​On Australia Day 2012 Dr Pearce was admitted to the ORDER OF AUSTRALIA (AM) for service to medicine as a general practitioner, through contributions to national medical organisations, and to education.
Today, Dr Pearce continues as a board member of the Immunisation Coalition as Head of GP Liaison and holds positions on several other boards. He was a member of the South Australian Meningococcal B Expert Working Group that was established in 2018 to provide the Minister for Health and Wellbeing with recommendations regarding the optimal meningococcal B vaccination program for South Australia.

Osteoporosis affects more than half of the population over 50; less than one in four are offered screening and the majority of people find out they have it after they have experienced an osteoporotic fracture. Early intervention and appropriate lifestyle changes (and treatment where appropriate) can make a meaningful difference for people and reduce the risk of a first, or second fracture.
This will be an interactive workshop focusing on:
∞∞ Osteoporosis as a disease state in primary care, which can be identified and managed
∞∞ Osteoporosis as a chronic disease which can be identified and managed in primary care
∞∞ Practical solutions which a busy practice can implement to make a difference for patients
The purpose of the session is to provide delegates with insights into the small but meaningful changes that can be made in a primary care centre with multiple priorities and issues to make changes to the way chronic diseases are identified, recalled and managed.

This session will be delivered by local nurse leader Jane Bollen.

Cart

Cart

Item removed. Undo